A summary of Syngenta’s consolidated financial statements is provided on pages 46 to 53. For full details and analysis of the Group’s  audited financial results, prepared in accordance with IFRS, please refer to our comprehensive Financial Report 2011 which is available  on request or on our website www.syngenta.com/ir Financial information Summarized financial information 2011 and 2010 1 For further discussion of restructuring and impairment charges, see page 52. Net income and earnings per share excluding restructuring and impairment are provided as  additional information and not as an alternative to net income and earnings per share determined in accordance with IFRS 2 The weighted average number of ordinary shares in issue used to calculate the earnings per share were as follows: For 2011 basic EPS 91,892,275 and diluted 92,383,611;  for 2010 basic EPS 92,687,903 and diluted 93,225,303 3 For a description of CER see page 52 4 EBITDA is defined on page 52 5 For a description of free cash flow, see page 52 6 Period end trade working capital as a percentage of twelve-month sales 7 For a description of net debt and the calculation of debt/equity gearing, see page 52 8 For a description of the cash flow return on investment calculation, see page 52 Excluding restructuring and impairment 1 Restructuring and impairment As reported under IFRS For the year ended December 31 (US$m, except per share amounts) 2011 2010 2011 2010 2011 2010 Sales 13,268 11,641 – – 13,268 11,641 Gross profit 6,545 5,793 (14) (18) 6,531 5,775 Marketing and distribution (2,145) (1,892) – – (2,145) (1,892) Research and development (1,127) (1,032) – – (1,127) (1,032) General and administrative (977) (899) – – (977) (899) Restructuring and impairment – – (231) (159) (231) (159) Operating income 2,296 1,970 (245) (177) 2,051 1,793 Income before taxes 2,146 1,855 (245) (178) 1,901 1,677 Income tax expense (356) (317) 55 42 (301) (275) Net income 1,790 1,538 (190) (136) 1,600 1,402 Attributable to non-controlling interests (1) (5) – – (1) (5) Attributable to Syngenta AG shareholders: 1,789 1,533 (190) (136) 1,599 1,397 Earnings/(loss) per share (US$) 2 Basic 19.47 16.54 (2.07) (1.47) 17.40 15.07 Diluted 19.36 16.44 (2.05) (1.45) 17.31 14.99 2011 2010 2011  CER 3 Gross profit margin excluding restructuring and impairment 49.3% 49.8% 50.4% EBITDA 4 2,905 2,505 EBITDA margin 21.9% 21.5% 22.8% Tax rate on results excluding restructuring and impairment 16.6% 17.1% Free cash flow  5 1,537 1,129 Trade working capital to sales  6 30% 33% Debt/equity gearing  7 15% 20% Net debt  7 1,135 1,473 Cash flow return on investment  8 14% 13% Syngenta Annual Review 2011 46 References to EBITDA in the following financial information excludes the impact of restructuring, impairment and discontinued operations. 1